lamivudine and zidovudine tablet film coated

1 INDICATIONS AND USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)

camber pharmaceuticals, inc.

FDA Reported Adverse Reactions
`[1] toxicity to various agents` `[2] completed suicide` `[3] drug abuse` `[4] drug ineffective` `[5] nausea` `[6] fatigue` `[7] drug interaction` `[8] dyspnoea` `[9] diarrhoea` `[10] death`

3 years ago

OVAL WHITE H 2

16 HOW SUPPLIED/STORAGE AND HANDLING

LAMIVUDINE AND ZIDOVUDINE Tablets, USP containing 150 mg lamivudine and 300 mg zidovudine, are white, film coated, capsule shaped tablets debossed with 'H' and score line on one side and '2' on other side. They are available as follows: 60 Tablets/Bottle (NDC 31722-506-60) 500 Tablets/Bottle (NDC 31722-506-05) Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature]

More pills like OVAL H 2